Australia markets closed

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3100-0.1200 (-8.39%)
At close: 04:00PM EDT
1.3199 +0.01 (+0.76%)
After hours: 07:53PM EDT
Full screen
Loading interactive chart…
  • PR Newswire

    TCBP Adjourns General Meeting Until a Later Date

    TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has adjourned its General Meeting of the Company to a later date.

  • PR Newswire

    TCBP Announces Exercise of Series D Warrants For Cash

    TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that an institutional investor has exercised cash only warrants represented 623,750 American Depository Shares (ADS) at an exercise price of $2.02.

  • PR Newswire

    Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"

    TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that Chief Executive Officer, Bryan Kobel was again featured on a live interview on "The Big Biz Show," an Emmy Award-winning nationally syndicated TV and radio show.